Not applicableStudy completedNCT00900302What this trial is testingOX-40 Protein Expression in the Sentinel Lymph Nodes of Patients With CancerWho this might be right forCancer OHSU Knight Cancer Institute 98
Early research (Phase 1)Ended earlyNCT00023790What this trial is testingPhotodynamic Therapy in Treating Patients With Skin Cancer or Solid Tumors Metastatic to the SkinWho this might be right forBreast CancerHead and Neck CancerLymphoma+3 more Case Comprehensive Cancer Center 3
Not applicableStudy completedNCT00896896What this trial is testingImmunoreactivity to Cetuximab in Cancer PatientsWho this might be right forColorectal CancerHead and Neck Cancer Vanderbilt-Ingram Cancer Center 538
Very early researchLooking for participantsNCT06914999What this trial is testingComparing an Investigational Scan (F-18 NaF PET/CT) to Standard of Care Imaging (F-18 FDG PET/CT) for Evaluating Vascular Complications in Patients Receiving Radiation Therapy for Head and Neck CancerWho this might be right forClinical Stage I HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8Clinical Stage II HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8Clinical Stage III HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8+13 more Emory University
Not applicableStudy completedNCT00828516What this trial is testingUsing Traditional Acupuncture in the Management of Cancer Treatment Related LymphoedemaWho this might be right forBreast CancerHead and Neck CancerLymphedema East and North Hertfordshire NHS Trust 56
Testing effectiveness (Phase 2)Study completedNCT00005087What this trial is testingPaclitaxel, Cisplatin, and Filgrastim Combined With Radiation Therapy in Treating Patients With Locally Recurrent Head and Neck CancerWho this might be right forHead and Neck Cancer Radiation Therapy Oncology Group 105
Early research (Phase 1)Study completedNCT00404339What this trial is testingVaccine Therapy in Treating Patients With Head and Neck CancerWho this might be right forHead and Neck Cancer Robert Ferris 17
Early research (Phase 1)WithdrawnNCT01332279What this trial is testingEverolimus, Erlotinib Hydrochloride, and Radiation Therapy in Treating Patients With Recurrent Head and Neck Cancer Previously Treated With Radiation TherapyWho this might be right forRecurrent Metastatic Squamous Neck Cancer With Occult PrimaryRecurrent Salivary Gland CancerRecurrent Squamous Cell Carcinoma of the Hypopharynx+8 more Fox Chase Cancer Center
Testing effectiveness (Phase 2)Study completedNCT00003582What this trial is testingRadiation Therapy, Combination Chemotherapy, and Amifostine in Treating Patients With Head and Neck CancerWho this might be right forCarcinoma of Unknown PrimaryHead and Neck Cancer University of Miami 36
Not applicableLooking for participantsNCT00898638What this trial is testingTissue Sample Collection From Patients With Head and Neck Cancer and From Healthy ParticipantsWho this might be right forHead and Neck Cancer Vanderbilt University Medical Center 8,000
Early research (Phase 1)Active Not RecruitingNCT04533750What this trial is testingTesting the Addition of M3814 (Peposertib) to Radiation Therapy for Patients With Advanced Head and Neck Cancer Who Cannot Take CisplatinWho this might be right forAdvanced Head and Neck Squamous Cell CarcinomaAdvanced Hypopharyngeal Squamous Cell CarcinomaAdvanced Laryngeal Squamous Cell Carcinoma+15 more National Cancer Institute (NCI) 21
Early research (Phase 1)Study completedNCT02381535What this trial is testingOnalespib in Treating Patients With Locoregionally Advanced Squamous Cell Carcinoma of the Head and Neck Receiving Radiation Therapy and CisplatinWho this might be right forStage III Hypopharyngeal Squamous Cell Carcinoma AJCC v7Stage III Laryngeal Squamous Cell Carcinoma AJCC v6 and v7Stage III Oral Cavity Squamous Cell Carcinoma AJCC v6 and v7+9 more National Cancer Institute (NCI) 2
Testing effectiveness (Phase 2)Study completedNCT00101348What this trial is testingErlotinib and Cetuximab With or Without Bevacizumab in Treating Patients With Metastatic or Unresectable Kidney, Colorectal, Head and Neck, Pancreatic, or Non-Small Cell Lung CancerWho this might be right forMetastatic Squamous Neck Cancer With Occult Primary Squamous Cell CarcinomaRecurrent Adenoid Cystic Carcinoma of the Oral CavityRecurrent Basal Cell Carcinoma of the Lip+64 more National Cancer Institute (NCI) 66
Not applicableStudy completedNCT03032250What this trial is testingPrepare to Care, A Supported Self-Management Intervention for Head and Neck Cancer CaregiversHead and Neck CancerWho this might be right forCaregiverMalignant Head and Neck NeoplasmParanasal Sinus Squamous Cell Carcinoma+35 more Wake Forest University Health Sciences 35
Early research (Phase 1)Study completedNCT01064921What this trial is testingPh I Vorinostat in the Treatment of Advanced Staged Oropharyngeal Squamous Cell CarcinomaWho this might be right forStage III Squamous Cell Carcinoma of the OropharynxStage IV Squamous Cell Carcinoma of the Oropharynx Ohio State University Comprehensive Cancer Center 27
Testing effectiveness (Phase 2)Study completedNCT00352105What this trial is testingCisplatin, Fluorouracil, Iressa, and Radiation Therapy Patients With Locally Advanced Head and Neck CancerWho this might be right forHead and Neck Cancer David Adelstein 60
Early research (Phase 1)Study completedNCT00004246What this trial is testingRadiation Therapy Plus Fludarabine in Treating Patients With Locally Advanced Cancer of the Mouth, Pharynx, or LarynxWho this might be right forHead and Neck Cancer M.D. Anderson Cancer Center 16
Testing effectiveness (Phase 2)Study completedNCT00006051What this trial is testingCombination Chemotherapy Plus Radiation Therapy in Treating Patients With Head and Neck CancerWho this might be right forHead and Neck Cancer UNICANCER
Testing effectiveness (Phase 2)Study completedNCT00030576What this trial is testingErlotinib and Cisplatin in Treating Patients With Recurrent or Metastatic Head and Neck CancerWho this might be right forHead and Neck Cancer University Health Network, Toronto 51
Testing effectiveness (Phase 2)Study completedNCT00058006What this trial is testingCelecoxib in Treating Patients With Early-Stage Head and Neck Cancer or Non-Small Cell Lung CancerWho this might be right forHead and Neck CancerLung Cancer Northwestern University